Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

SELL
$183.43 - $232.67 $10,822 - $13,727
-59 Reduced 0.04%
139,901 $26.2 Billion
Q1 2023

May 11, 2023

BUY
$193.75 - $232.55 $199,368 - $239,293
1,029 Added 0.74%
139,960 $32.5 Million
Q4 2022

Jan 27, 2023

BUY
$187.24 - $242.74 $644,105 - $835,025
3,440 Added 2.54%
138,931 $0
Q3 2022

Nov 01, 2022

BUY
$177.23 - $227.44 $5.26 Million - $6.75 Million
29,666 Added 28.03%
135,491 $25.9 Million
Q2 2022

Aug 25, 2022

BUY
$181.58 - $368.0 $2.1 Million - $4.25 Million
11,555 Added 12.26%
105,825 $19.5 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $6.57 Million - $9.17 Million
21,628 Added 29.77%
94,270 $32.9 Million
Q4 2021

Jan 18, 2022

SELL
$347.28 - $421.83 $6.47 Million - $7.86 Million
-18,636 Reduced 20.42%
72,642 $27.6 Million
Q3 2021

Nov 09, 2021

BUY
$405.61 - $524.84 $3.2 Million - $4.14 Million
7,885 Added 9.46%
91,278 $37 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $13.5 Million - $17.5 Million
36,329 Added 77.19%
83,393 $39.4 Million
Q1 2021

May 12, 2021

BUY
$361.28 - $504.76 $2.77 Million - $3.87 Million
7,662 Added 19.45%
47,064 $18.1 Million
Q4 2020

Feb 02, 2021

BUY
$292.7 - $370.96 $1.95 Million - $2.48 Million
6,675 Added 20.4%
39,402 $14.6 Million
Q3 2020

Oct 26, 2020

BUY
$268.51 - $400.74 $1.52 Million - $2.27 Million
5,653 Added 20.88%
32,727 $10.1 Million
Q2 2020

Jul 22, 2020

BUY
$256.46 - $373.01 $2.5 Million - $3.64 Million
9,749 Added 56.27%
27,074 $10 Million
Q1 2020

Apr 09, 2020

BUY
$209.2 - $335.53 $1.77 Million - $2.83 Million
8,443 Added 95.06%
17,325 $4.73 Million
Q4 2019

Jan 28, 2020

BUY
$288.29 - $335.49 $2.56 Million - $2.98 Million
8,882 New
8,882 $2.95 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.